339 related articles for article (PubMed ID: 15023479)
1. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
2. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
Greil W; Kleindienst N
Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
[TBL] [Abstract][Full Text] [Related]
3. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
Greil W; Kleindienst N
Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
[TBL] [Abstract][Full Text] [Related]
4. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
5. A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Jairam R; Srinath S; Girimaji SC; Seshadri SP
Bipolar Disord; 2004 Oct; 6(5):386-94. PubMed ID: 15383131
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of schizoaffective disorder: review and recommendations.
Baethge C
Pharmacopsychiatry; 2003; 36(2):45-56. PubMed ID: 12734761
[TBL] [Abstract][Full Text] [Related]
9. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
10. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
12. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
[TBL] [Abstract][Full Text] [Related]
13. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
Post RM; Leverich GS; Kupka RW; Keck PE; McElroy SL; Altshuler LL; Frye MA; Luckenbaugh DA; Rowe M; Grunze H; Suppes T; Nolen WA
J Clin Psychiatry; 2010 Jul; 71(7):864-72. PubMed ID: 20667291
[TBL] [Abstract][Full Text] [Related]
14. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
Yazici O; Kora K; Polat A; Saylan M
J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
16. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine in the prophylaxis of major depression: a 5-year follow-up.
Stuppaeck CH; Barnas C; Schwitzer J; Fleischhacker WW
J Clin Psychiatry; 1994 Apr; 55(4):146-50. PubMed ID: 8071258
[TBL] [Abstract][Full Text] [Related]
18. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
[TBL] [Abstract][Full Text] [Related]
19. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study.
Greil W; Ludwig-Mayerhofer W; Erazo N; Engel RR; Czernik A; Giedke H; Müller-Oerlinghausen B; Osterheider M; Rudolf GA; Sauer H; Tegeler J; Wetterling T
Eur Arch Psychiatry Clin Neurosci; 1997; 247(1):42-50. PubMed ID: 9088805
[TBL] [Abstract][Full Text] [Related]
20. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
